Improving pediatric dosing through pediatric initiatives: what we have learned. - Wikidata - wikimedia - TriplyDB

Improving pediatric dosing through pediatric initiatives: what we have learned.

Improving pediatric dosing through pediatric initiatives: what we have learned.

http://www.wikidata.org/entity/Q37098241

about

Innovative clinical trial design for pediatric therapeutics Modelling and simulation as research tools in paediatric drug development Anesthetic use in newborn infants: the urgent need for rigorous evaluation Therapeutic options for acute cough due to upper respiratory infections in children Clinical research careers: reports from a NHLBI pediatric heart network clinical research skills development conference To scale or not to scale: the principles of dose extrapolation Part 10: Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.Changes in individual drug-independent system parameters during virtual paediatric pharmacokinetic trials: introducing time-varying physiology into a paediatric PBPK model Status of the pediatric clinical trials enterprise: an analysis of the US ClinicalTrials.gov registry.Analysis of pediatric clinical drug trials for neuropsychiatric conditions Children's medicines in Tanzania: a national survey of administration practices and preferences Paediatric pharmacokinetics: key considerations.Lessons learned in pediatric clinical research to evaluate safe and effective use of drugs in pregnancy.An empirical review of major legislation affecting drug development: past experiences, effects, and unintended consequences.The plight of paediatric drug therapy.Population pharmacokinetics of methylphenidate hydrochloride extended-release multiple-layer beads in pediatric subjects with attention deficit hyperactivity disorder.Patterns of Off-Label Prescribing in the Pediatric Intensive Care Unit and Prioritizing Future Research Detection of an endogenous urinary biomarker associated with CYP2D6 activity using global metabolomics Observational infant exploratory [(14)C]-paracetamol pharmacokinetic microdose/therapeutic dose study with accelerator mass spectrometry bioanalysis.Role of the Pharmacist in Caring for Patients with HIV/AIDS: Clinical Practice Guidelines.Special populations and pharmacogenetic issues in tuberculosis drug development and clinical research Approach to the pediatric prescription in a community pharmacy.Personalised medicine in paediatrics: individualising treatment in children with rare neurological diseases.Management of anemia in children receiving chronic peritoneal dialysis.Population pharmacokinetic analysis of sifalimumab from a clinical phase IIb trial in systemic lupus erythematosus patients Drug delivery trends in clinical trials and translational medicine: evaluation of pharmacokinetic properties in special populations Optimizing drug development of anti-cancer drugs in children using modelling and simulation.Recent developments and strategies in pediatric pharmacology research in the USA.Pediatric basic and advanced life support: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations.Using registries to identify adverse events in rheumatic diseases.Pediatric antihypertensive trial failures: analysis of end points and dose range.Pediatric Dosing and Body Size in Biotherapeutics.Systematic review of safety in paediatric drug trials published in 2007 The role of physiologically based pharmacokinetic modeling in regulatory review.Pediatric pharmacogenomics: a systematic assessment of ontogeny and genetic variation to guide the design of statin studies in children.The impact of the written request process on drug development in childhood cancer.Methods for pharmacokinetic analysis in young children.Present state and future challenges in pediatric abdominal pain therapeutics research: Looking beyond the forest.Impact of disease, drug and patient adherence on the effectiveness of antiviral therapy in pediatric HIV.Medication Dosage in Overweight and Obese Children.

P2860

Q24635308-7A277E6B-6FEC-463F-A9A9-A8335F5AFF93 Q27010366-113515CC-756B-44B6-9278-87AE8E27223E Q28088630-9DB39D1B-FD3C-47B4-AA49-EBA3016E5BD4 Q28247163-56A087AD-5326-4224-99D4-D4E72F4CDAEF Q28703857-6EB21B7A-C32A-4B16-871D-A28666287003 Q28751735-2CEBD294-1BA3-4FA4-894B-DBA504C89F31 Q30543305-71744B31-0419-42DC-A024-19C865D1A261 Q33574126-D18EC0E7-41A3-48E3-948A-E80BA9439965 Q33819664-1E8DB869-A180-4EE6-BF3E-0DBD42A5065C Q33819758-0D7F92C2-2C82-4190-966C-4907CF9F41CA Q34618746-0FFA3783-CDDC-4482-BF23-E45BA7F6F4C9 Q35135940-EA0E9116-459B-4EAE-8AC8-F80E00B481AD Q35214105-460EDD7A-13E8-43DB-A2D1-A4C23290903D Q35545776-CD818A9C-2E2F-4575-8EA1-A20A96F5CACA Q35572591-3B0D3EB6-A109-4AF5-B91C-317BB19BF0F1 Q35679400-30D6720C-8B21-4274-9E3D-835CA044C336 Q35754041-77405D8B-DACF-4D06-BCC8-28D4025D7EAA Q35800807-82584724-D69E-4324-9E4B-95DE0D6194D4 Q35846147-EDD35E09-79FD-432E-885C-EAF02E08B82D Q35898538-DABE9252-2C9C-400D-B9CE-F9361B0E95AE Q36000004-225452A6-1FB4-4C40-9158-4D4DF9560182 Q36063819-94C6F1A9-FD6C-4482-AE4F-835B39968074 Q36117928-A156355D-8FA5-4E31-B3F2-D95B07583E8D Q36719231-A499B527-930B-4DF1-B94C-3B0A259C92D7 Q36806646-93DC0C2B-8C1B-4247-9042-04F735071ABC Q36901627-796B75A2-FA0B-4588-9781-A80B5BB9C981 Q36987975-6DB79AB8-E181-4B8E-A711-19379B9185D6 Q37040160-E0835BC5-D2FB-4559-875B-E2F5386345A2 Q37200292-D5A526D8-9284-47C9-9930-FAC3B21C6C2E Q37268816-8CA091C4-1AEC-45C2-BCB3-ED7821B6641E Q37436147-BDA0DBC4-A92F-470F-8F45-2E7C7CA2F4FC Q37666711-2F6C87C9-DE54-4654-ADA3-4BA9DC5F70F9 Q37920751-6B805072-278F-4B0B-887C-1A5B278FCAD3 Q37982653-118D1B69-8751-4E11-A489-4247964D69C4 Q38049379-AF829255-EA40-43A6-A355-CDE1C0F4AB1D Q38075541-63981F67-AC8D-49EE-B808-6908B1E07A92 Q38187157-2D897795-FFF7-4594-8C3A-2C5DCFD8F95C Q38630447-AFD79097-252B-4C1C-9890-457909885F64 Q39064765-03D8D401-1BA7-4EE6-94B0-2D96A40E8671 Q41892663-D8F28E14-9C12-4623-BB4E-D5E562F3E648

P2860

Improving pediatric dosing through pediatric initiatives: what we have learned.

http://www.wikidata.org/entity/Q37098241

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Improving pediatric dosing through pediatric initiatives: what we have learned.

@en

Improving pediatric dosing through pediatric initiatives: what we have learned.

@nl

type

label

Improving pediatric dosing through pediatric initiatives: what we have learned.

@en

Improving pediatric dosing through pediatric initiatives: what we have learned.

@nl

prefLabel

Improving pediatric dosing through pediatric initiatives: what we have learned.

@en

Improving pediatric dosing through pediatric initiatives: what we have learned.

@nl

P1433

Q37098241-50DA81BC-C760-41A3-BAEC-CA0AA6EF6AF0

P1476

Q37098241-0A0526C4-62C1-44FD-A0D2-2E9661B1BDDD

P2093

Q37098241-006F2533-1CAE-4ED7-877A-1C84EBF6BB4F

Q37098241-20E8F02A-B2AA-4A7C-A8F4-EAB6FCB90542

Q37098241-31FA2F4C-E4B6-42FF-850F-C440C5E331BF

Q37098241-37D21956-9E6E-4DC5-A229-67945B8B879F

Q37098241-44AD1605-F6D4-41CB-85ED-932833B5A918

Q37098241-4905BA2F-0AC1-4D2E-A24A-38C586914896

Q37098241-4B6728E0-5EBD-427A-B96E-92A904B0E1AB

Q37098241-501B8039-0BDD-4773-A5B6-97F99CD6213E

Q37098241-6F09BE40-8C58-44CC-98DC-585F416E8ECD

Q37098241-85D66CAF-D983-456C-9F09-B1A747F3392E

P304

Q37098241-E16A3BFC-0067-458D-823C-7125EAD4B074

P31

Q37098241-93949354-E1D7-4DDB-9A13-F4BE4518C476

P356

Q37098241-C08ACD7E-390B-429B-B124-47FFE5410C49

P407

Q37098241-4E57F592-F0B1-464A-9F89-F2A9F9D2E1AE

P433

Q37098241-B335F9B0-1C89-4F73-88FD-48C5F660524D

P478

Q37098241-925E58B8-9882-47B0-AA4D-C74CAD0EF07F

P577

Q37098241-422F76F8-09D3-48D5-BD81-E31A4830DBC4

P698

Q37098241-15D9E4CA-2985-440B-AC9B-B84B0183AD6F

P356

P1433

P1476

Improving pediatric dosing through pediatric initiatives: what we have learned.

@en

P2093

Arzu Selen

http://www.w3.org/2001/XMLSchema#string

Chandra Chaurasia

http://www.w3.org/2001/XMLSchema#string

Debbie Avant

http://www.w3.org/2001/XMLSchema#string

Dianne Murphy

http://www.w3.org/2001/XMLSchema#string

Gerlie Gieser

http://www.w3.org/2001/XMLSchema#string

Hari Cheryl Sachs

http://www.w3.org/2001/XMLSchema#string

Jennifer Di Giacinto

http://www.w3.org/2001/XMLSchema#string

Lisa Mathis

http://www.w3.org/2001/XMLSchema#string

Peter Lee

http://www.w3.org/2001/XMLSchema#string

Ramana S Uppoor

http://www.w3.org/2001/XMLSchema#string

P304

530-539

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1542/PEDS.2007-1529

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18310202

http://www.w3.org/2001/XMLSchema#string